This site is intended for Healthcare Professionals only

type 2 diabetes

semaglutide-summary
Public health

Off-label use of diabetes drugs to drive ‘critical’ shortages until mid-2024, says MHRA

No new patients to be started on GLP-1 receptor agonists, says MHRA in 'critical' alert

19 Jul 2023 , 1 Min Article